Our partners

Our partners

IPI has built global alliances with European pharmaceutical companies through a history of many successful collaborations.

Learn more

Our science

Our science

Our patient-centric culture focuses on innovation to cure oncology diseases, investing in science to enhance lives.

Learn more

Our certificates

Our certificates

Leading the pharmaceutical industry with advanced technology, rigorous quality control, and ISO/class-A certifications.

Learn more

Check our medicine

Check our medicine

“The first wealth is health” – Ralph Waldo Emerson

We are a renowned pharmaceutical company, developing and producing top-tier medications distributed locally and globally. Our goal aim is to provide the finest healthcare solutions to enhance patients’ lives and create a brighter tomorrow.

See all the products

Paracetin 500 mg
Antihist 4 mg
Ponstole 500 mg
Mebendazole Tablets
Pms-Decitabine 50 mg
Bosutinib IPI 100, 400, and 500 mg
Imatinib IPI 100 and 400 mg
Ibrutinib IPI 140 mg
Sunitinib IPI 12.5, 25, and 50 mg
Ruxolitinib IPI 5 and 15 mg
Ipijade Tablets 125, 250, and 500 mg
Abiraterone IPI 250mg
Palbociclib 125mg
Labmaryl 1, 2, 3, 4mg
Lenalidomide 10 and 25 mg
Nilotinib 150mg
Ipisone Tablets
Flu-Stop
Periahist Tablets 4 mg
Gastricure Chewable Tablets
Isoniazid Tablets 100mg

Why Choose Us?

about us
Newest Technology
Newest Technology

We are a leader in medical advancement; we use cutting-edge technologies, including computational biology, AI, and high-throughput screening, to identify novel drug candidates.

Tested and Verified
Tested and Verified

All manufactured products are tested and verified to ensure compliance with international standards before they are packaged and distributed

Highest Quality
Highest Quality

With more than 67 years in the industry, we pride ourselves on always manufacturing medicines with the highest quality using our state-of-the-art laboratories equipped with the latest technology and quality control equipment.

Science First
Science First

Scientific innovation is central to our mission, driving progress in healthcare, technology, and societal challenges. We enhance well-being and unify society through pioneering discoveries and advancements.

 

 

 

0

Years of experience

0

List of products

0

Number of certificates

0

Global network

Our Recent News

29 07/24

IPI Achieves a Milestone for Iraq's Pharmaceutical Industry

IPI
We are proud to continue setting new benchmarks in the pharmaceutical industry. In a historic achievement for Iraq, we have authorized PHARMACARE to manufacture Palbociclib IPI, a vital breast cancer medication. This pivotal development has attracted considerable attention from the media.
22 05/24

Exploring IPI's Global Network

IPI
At IPI, we pioneer pharmaceutical and healthcare advancements globally through strategic partnerships, uniting expertise to develop cutting-edge solutions, enhance patient care, and tackle diverse healthcare challenges.
26 04/24

Basra Summit: Fostering Progress in Blood Disease Treatment

IPI
The Iraqi Blood Diseases Summit in Basra brought together leading experts and doctors to collaborate on advancing the field. It aimed to drive progress in research, diagnosis, and treatment methods for blood disorders, ultimately improving healthcare outcomes.
The Evolution of IPI

The Evolution of IPI

IPI
06 04/23

IPI Leads Nation in Local Cancer Drug Production

IPI
Iraq's pharmaceutical industry has achieved a significant milestone by locally producing cancer drugs for the first time. Under the guidance of Minister of Health Dr. Saleh Al-Hasnawi, the Ministry has partnered with Iraqi factories to improve medicine production. The Iraq Pharmaceutical Industry (IPI), established in 1954, meets European standards and has notably reduced costs. This accomplishment brings Iraq one step closer to pharmaceutical self-sufficiency, guaranteeing quality healthcare for its citizens.
12 05/24

Global Engagement

IPI
During our attendance at the World Pharmaceutical Components Conference (#IPIpharma) in Barcelona, Spain, we proudly presented our Iraqi-produced medicines (#CPhI). We also engaged in a wide range of discussions, covering topics from the next generation of biomanufacturing to innovations in sustainable solutions within the pharmaceutical sector.
30 03/24

Launching Conference of IPI Pharma Company

IPI
The launching conference of the Iraqi Pharmaceutical Industry Company showcased a 90% attendance rate among healthcare providers, underscoring our dedication to delivering high-quality oncology and hematology medications. This event culminated in a strategic partnership aimed at advancing healthcare standards in Iraq.

Our videos

IPI Evolution
IPI Evolution
Pharmacovigilance at IPI
Pharmacovigilance at IPI

© Copyrights 2024. All rights reserved. Designed by